Article Versions Notes

Jourdain M, Benchaib M, Ploin D, Gillet Y, Javouhey E, Horvat C, Massoud M, Butin M, Claris O, Lina B, et al. Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN). Vaccines. 2022; 10(5):729. https://doi.org/10.3390/vaccines10050729

Jourdain, Marine, Mehdi Benchaib, Dominique Ploin, Yves Gillet, Etienne Javouhey, Come Horvat, Mona Massoud, Marine Butin, Olivier Claris, Bruno Lina, and et al. 2022. "Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN)" Vaccines 10, no. 5: 729. https://doi.org/10.3390/vaccines10050729

Jourdain, M., Benchaib, M., Ploin, D., Gillet, Y., Javouhey, E., Horvat, C., Massoud, M., Butin, M., Claris, O., Lina, B., Casalegno, J.-S., & on behalf of the VRS study group in Lyon. (2022). Identifying the Target Population for Primary Respiratory Syncytial Virus Two-Step Prevention in Infants: Normative Outcome of Hospitalisation Assessment for Newborns (NOHAN). Vaccines, 10(5), 729. https://doi.org/10.3390/vaccines10050729